Nucleus

Trending topics and news in HCT and Cellular Therapy

Topics to Explore

Topics to Explore

ASTCT News

Reviewing Real-World Use of Beti-Cel in Transfusion-Dependent β-Thalassemia

by ASTCT Talks

In a special co-branded episode between Oncology On theGo hosted by CancerNetwork® and the American Society for Transplantation and Cellular Therapy (ASTCT)’s program ASTCT Talks, Nora...

ASTCT News

Key CAR T and Transplantation Presentations From The 2025 Tandem Meetings

by ASTCT Talks

CancerNetwork®, in collaboration with the American Society for Transplantation and Cellular Therapy (ASTCT)®, hosted a Twitter/X Space during the 2025 Tandem Meetings. The live...

ASTCT News

Building Bridges, Fueling Progress: ASTCT’s Spring Highlights

by David Porter, MD

In this month's president's message, Dr. David Porter shares highlights from the recent two-day Leadership Course in Washington, D.C., celebrating the connections between rising and...

ASTCT News

Understanding Cutaneous GVHD: Clinical Insights and Care Strategies

by ASTCT Talks

Welcome to the fourth episode of ASTCT Talks’ exclusive 8-part series, supported by an educational grant from Sanofi US. In this episode, former ASTCT President Dr. Corey Cutler sits down...

ASTCT News

ASTCT Women’s History Month Spotlight: Sophie Paczesny, MD, PhD

by Sophie Paczesny, MD, PhD

In celebration of Women’s History Month, ASTCT is proud to highlight the inspiring journeys of women making a profound impact in transplantation and cellular therapy. This spotlight features...

ASTCT News

ASTCT Women’s History Month Spotlight: LeAnne Kennedy, PharmD, BCOP, FHOPA, FASTCT

by LeAnne Kennedy, PharmD, BCOP, FHOPA, FASTCT

In celebration of Women’s History Month, ASTCT is proud to highlight the inspiring journeys of women making a profound impact in transplantation and cellular therapy. This spotlight features...

RELATED NEWS

GVHD

High Melphalan Exposure Increases the Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation

by Alex Kadhim

In a recent study, researchers from the University of California, San Francisco, have demonstrated that high exposure to melphalan significantly increases the risk of graft-versus-host disease...

CAR T

PTGFRN CAR-T cell therapy studied as a potential therapeutic target for glioblastoma

by Cancer Immunology, Immunotherapy

Scientists believe prostaglandin F2 receptor negative regulator (PTGFRN) is a possible target for chimeric antigen receptor (CAR) T-cell therapy in patients with glioblastoma (GBM).